Onconova Logo BLUE.jpg
Onconova Therapeutics Announces Participation at the Upcoming H.C. Wainwright 23rd Annual Global Investment Conference
September 09, 2021 08:00 ET | Onconova Therapeutics, Inc.
NEWTOWN, Pa., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
Onconova Logo BLUE.jpg
Onconova Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
August 12, 2021 16:05 ET | Onconova Therapeutics, Inc.
NEWTOWN, Pa., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
Onconova Logo BLUE.jpg
Onconova Therapeutics Regains Compliance with Nasdaq Continued Listing Requirement
June 22, 2021 08:00 ET | Onconova Therapeutics, Inc.
NEWTOWN, Pa., June 22, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products for patients...
Onconova Logo BLUE.jpg
Onconova Therapeutics Announces Participation in A.G.P.’s Upcoming Virtual Summer Healthcare Symposium
June 10, 2021 08:00 ET | Onconova Therapeutics, Inc.
NEWTOWN, Pa., June 10, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
Onconova Logo BLUE.jpg
Onconova Therapeutics Announces Upcoming Presentation at 2021 BIO Digital
June 03, 2021 08:00 ET | Onconova Therapeutics, Inc.
NEWTOWN, Pa., June 03, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
Onconova Logo BLUE.jpg
Onconova Therapeutics Announces the Initial Dosing of the First Patient in the U.S. Phase 1 Clinical Trial of ON 123300
May 21, 2021 08:00 ET | Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 21, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
Onconova Logo BLUE.jpg
Onconova Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
May 17, 2021 16:05 ET | Onconova Therapeutics, Inc.
Conference call and live webcast at 4:30 p.m. ET today NEWTOWN, Pa., May 17, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a clinical-stage biopharmaceutical...